Neuroderm Ltd Ord Sh (NDRM)
38.85 -0.05 (-0.13%) 10/17/17 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,496 | -15,609 | -29,864 | -86,893 | -4,570 |
| Depreciation Amortization | 90 | 44 | 43 | 35 | 33 |
| Accounts payable and accrued liabilities | 2,725 | 373 | 1,015 | 852 | 193 |
| Other Working Capital | 660 | -891 | 986 | 577 | 523 |
| Other Operating Activity | 1,237 | 652 | 19,840 | 82,898 | 1,546 |
| Operating Cash Flow | $-27,784 | $-15,431 | $-7,980 | $-2,531 | $-2,275 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -30,000 | -14,965 | N/A | N/A | N/A |
| PPE Investments | -853 | -73 | -117 | -7 | -3 |
| Other Investing Activity | 0 | -54 | -50 | 677 | -672 |
| Investing Cash Flow | $-30,853 | $-15,092 | $-167 | $670 | $-675 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 81,046 | 72,024 | 49,230 | 3,200 | 4,300 |
| Financing Cash Flow | $81,046 | $72,024 | $49,230 | $3,200 | $4,300 |
| Exchange Rate Effect | N/A | -2,188 | -1,171 | -672 | 75 |
| Beginning Cash Position | 84,735 | 43,238 | 2,435 | 1,847 | 492 |
| End Cash Position | 107,178 | 84,735 | 43,238 | 2,435 | 1,847 |
| Net Cash Flow | $22,443 | $41,497 | $40,803 | $588 | $1,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,784 | -15,431 | -7,980 | -2,531 | -2,275 |
| Capital Expenditure | -853 | -73 | -120 | -7 | -3 |
| Free Cash Flow | -28,637 | -15,504 | -8,100 | -2,538 | -2,278 |